While polypharmacy is sometimes necessary, it can often lead to adverse drug events, increased costs, and cognitive or functional impairment. This program reviews the risks of polypharmacy and provides tools to support clinicians in identifying and reducing problematic polypharmacy, particularly through deprescribing. Using a patient case, this program will explore practical steps to review, assess and safely taper medications, so that clinicians are equipped with actionable steps to optimize medication use in practice.
Optimizing Medication Use: A Guide to Deprescribing
CAN-eng
$0
free
Mainpro+
30 min
Medication, Medication Management, Screening & Prevention
0.5 Credits
Course Description
Course Details
Expiry Date: 2026-05-08
Professions: Physician
Faculty
- Barbara Farrell, BScPhm, PharmD, FCSHP
- Robert Hauptman, BMSc, MD, MCFP
- Christine Palmay, MD, CCFP, FCFP
- Alan Kaplan, MD, CCFP(EM), FCFP, CPC(HC)
- Bilal Hatoum, BSc Pharm, RPh, APA, CDE
- Kristen Watt, RPh
Accreditation
This activity meets the certification criteria of the College of Family Physicians of Canada and the Quebec College of Family Physicians, a continuing professional development accrediting organization recognized by the Collège des médecins du Québec and has been approved for up to 0.5 Mainpro+® Certified Activity credit(s).
CERT+ Session ID : 203961-001
Learning Objective(s)
Upon completion of this continuing education program, participants will be better able to:
- Describe the potential consequences of polypharmacy
- Identify patients who may benefit from deprescribing one or more of their medications
- Implement appropriate strategies to deprescribe medication(s)